IRIS Accounts Production v24.3.0.553 08506049 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh085060492022-12-31085060492023-12-31085060492023-01-012023-12-31085060492022-05-31085060492022-06-012022-12-31085060492022-12-3108506049ns15:EnglandWales2023-01-012023-12-3108506049ns14:PoundSterling2023-01-012023-12-3108506049ns10:Director12023-01-012023-12-3108506049ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3108506049ns10:SmallEntities2023-01-012023-12-3108506049ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3108506049ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3108506049ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3108506049ns10:FullAccounts2023-01-012023-12-3108506049ns10:OrdinaryShareClass12023-01-012023-12-3108506049ns10:Director22023-01-012023-12-3108506049ns10:Director32023-01-012023-12-3108506049ns10:Director42023-01-012023-12-3108506049ns10:RegisteredOffice2023-01-012023-12-3108506049ns5:CurrentFinancialInstruments2023-12-3108506049ns5:CurrentFinancialInstruments2022-12-3108506049ns5:ShareCapital2023-12-3108506049ns5:ShareCapital2022-12-3108506049ns5:RetainedEarningsAccumulatedLosses2023-12-3108506049ns5:RetainedEarningsAccumulatedLosses2022-12-3108506049ns5:FurnitureFittings2023-01-012023-12-3108506049ns5:ComputerEquipment2023-01-012023-12-3108506049ns5:FurnitureFittings2022-12-3108506049ns5:ComputerEquipment2022-12-3108506049ns5:FurnitureFittings2023-12-3108506049ns5:ComputerEquipment2023-12-3108506049ns5:FurnitureFittings2022-12-3108506049ns5:ComputerEquipment2022-12-3108506049ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3108506049ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3108506049ns10:OrdinaryShareClass12023-12-3108506049ns5:RetainedEarningsAccumulatedLosses2022-12-3108506049ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-31
REGISTERED NUMBER: 08506049 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

HARVEY MEDICAL CONSULTING LIMITED

HARVEY MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 08506049)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


HARVEY MEDICAL CONSULTING LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTORS: Mrs Beatrice Louisa Harvey
Mr Joshua Boylan
Ms Kelley Henderson
Mr Xin Zhang





REGISTERED OFFICE: Copley Hill Business Park, Lower Court 6
Suites A, B and C
Cambridge Road, Babraham
Cambridge
CB22 3AF





REGISTERED NUMBER: 08506049 (England and Wales)





ACCOUNTANTS: Syers McGill
9 Kerry Street
Horsforth
Leeds
West Yorkshire
LS18 4AW

HARVEY MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 08506049)

BALANCE SHEET
31 DECEMBER 2023

31.12.23 31.12.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 8,317 6,561

CURRENT ASSETS
Stocks 180,640 68,530
Debtors 5 1,090,156 210,699
Cash at bank 58,457 61,257
1,329,253 340,486
CREDITORS
Amounts falling due within one year 6 1,099,593 109,259
NET CURRENT ASSETS 229,660 231,227
TOTAL ASSETS LESS CURRENT
LIABILITIES

237,977

237,788

CAPITAL AND RESERVES
Called up share capital 7 1 1
Retained earnings 8 237,976 237,787
SHAREHOLDERS' FUNDS 237,977 237,788

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

HARVEY MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 08506049)

BALANCE SHEET - continued
31 DECEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 March 2024 and were signed on its behalf by:





Mr Xin Zhang - Director


HARVEY MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 08506049)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023


1. STATUTORY INFORMATION

Harvey Medical Consulting Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Work in progress is valued at the lower of cost and net realisable value.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 12 (2022 - 7 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 January 2023 5,706 7,703 13,409
Additions 475 3,878 4,353
At 31 December 2023 6,181 11,581 17,762
DEPRECIATION
At 1 January 2023 2,076 4,772 6,848
Charge for year 1,366 1,231 2,597
At 31 December 2023 3,442 6,003 9,445
NET BOOK VALUE
At 31 December 2023 2,739 5,578 8,317
At 31 December 2022 3,630 2,931 6,561

HARVEY MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 08506049)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade debtors 996,695 191,812
Other debtors 3,400 5,895
Prepayments and accrued income 90,061 12,992
1,090,156 210,699

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Trade creditors 78,316 -
Amounts owed to group undertakings 428,247 -
Tax 12,009 60,447
Social security and other taxes 25,096 12,844
VAT 141,886 26,978
Accruals and deferred income 368,392 -
Accrued expenses 45,647 8,990
1,099,593 109,259

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.23 31.12.22
value: £    £   
1 Ordinary £1 1 1

8. RESERVES
Retained
earnings
£   

At 1 January 2023 237,787
Profit for the year 189
At 31 December 2023 237,976

HARVEY MEDICAL CONSULTING LIMITED (REGISTERED NUMBER: 08506049)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


9. RELATED PARTY DISCLOSURES

On 5 January 2023 Clarimed, Inc purchased the entire share capital of the company.

During the year Clarimed, Inc invoiced the company £272,951 in respect of corporate fees. At the balance sheet date the company owed Clarimed, Inc £386,878.

Userwise, Inc is a company under common control. At the balance sheet date the company owed Userwise, Inc £41,369.